Application of Newcastle disease virus in the treatment of colorectal cancer

doi:10.12998/wjcc.v7.i16.2143

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13349)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

737

WORD

328

HTML

9147

Figures (1-3)

605

Tables (1-1)

240

Sum=11057

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

389

Download

610

Sum=999

Publishing Process of This Article

Item

Count

Browse

550

Download

743

Sum=1293

Aug 26, 2019 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Aug 26, 2019; 7(16): 2143-2154
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2143

Full Size Figure Download Figure

Figure 3 Bispecific antibodies consisting of single-chain variable regions can be simultaneously targeted to viruses and immune cells. When NDV infects tumor cells, bispecific antibodies can target F or HN on the surface of tumor cells and can simultaneously target CD3, CD25 or CD28 on the surface of immune T cells. F: Fusion protein; HN: Hemagglutinin-neuraminidase; NDV: Newcastle disease virus.

Citation: Song H, Zhong LP, He J, Huang Y, Zhao YX. Application of Newcastle disease virus in the treatment of colorectal cancer. World J Clin Cases 2019; 7(16): 2143-2154
URL: https://www.wjgnet.com/2307-8960/full/v7/i16/2143.htm
DOI: https://dx.doi.org/10.12998/wjcc.v7.i16.2143